Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2008-12-12

FDA Approved: ELMIRON — Supplemental Application (Janssen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Elmiron (pentosan polysulfate sodium) from Janssen Pharmaceuticals, Inc. to update the product label.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Elmiron (pentosan polysulfate sodium)

Snippet

SUPPL AP for ELMIRON (PENTOSAN POLYSULFATE SODIUM)